Pharmacy benefit managers would be prohibited from accepting compensation based on the price or utilization of a drug as a condition of entering into a contract with a Medicare Part D plan, under a bill announced by the Senate Finance Committee on 14 June.
Separating compensation from price and utilization aims to address concerns that current practices encourage higher list prices and disadvantage patients...







